Analysed ATEA PHARMACEUTICALS INC (AVIR:NASDAQ) News Sources
Atea Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update
12-05-2026
yahoo.com
Atea Pharmaceuticals Inc (AVIR) Q1 2026 Earnings Call Highlights: Strategic Advancements and ...
13-05-2026
yahoo.com
Atea Pharmaceuticals to Present Three Abstracts at EASL 2026 Congress Highlighting Progress Across Viral Hepatitis Pipeline
13-05-2026
yahoo.com
Down 25% in 4 Weeks, Here's Why Atea Pharmaceuticals (AVIR) Looks Ripe for a Turnaround
15-05-2026
yahoo.com
Here's Why We're Watching Atea Pharmaceuticals' (NASDAQ:AVIR) Cash Burn Situation
19-05-2026
yahoo.com
Atea Pharmaceuticals Presents New Drug-Drug Interaction Results Supporting Potential Best-in-Class Profile of the Regimen of Bemnifosbuvir and Ruzasvir for the Treatment of Hepatitis C Virus at EASL Congress 2026
27-05-2026
yahoo.com
What is the current price of ATEA PHARMACEUTICALS INC (AVIR:NASDAQ)?
The current price of ATEA PHARMACEUTICALS INC (AVIR:NASDAQ) is $4.26.
ATEA PHARMACEUTICALS INC (AVIR:NASDAQ) absolute price change since previous trading day?
The absolute price change of ATEA PHARMACEUTICALS INC (AVIR:NASDAQ) since the previous trading day is $-0.09.
ATEA PHARMACEUTICALS INC (AVIR:NASDAQ) percentage price change since previous trading day?
The percentage price change of ATEA PHARMACEUTICALS INC (AVIR:NASDAQ) since the previous trading day is -2.069%.
What is the most recent average sentiment score for ATEA PHARMACEUTICALS INC (AVIR:NASDAQ)?
The most recent average sentiment score for ATEA PHARMACEUTICALS INC (AVIR:NASDAQ) is 72 out of 100.
What is the most recent average sentiment for ATEA PHARMACEUTICALS INC (AVIR:NASDAQ)?
The most recent sentiment for ATEA PHARMACEUTICALS INC (AVIR:NASDAQ) is .
SEC-8K** Filing Available For ATEA PHARMACEUTICALS INC (AVIR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.